{"ticker": {"uuid": "96dbb6ce-79d5-4703-9b8f-0772210222d9", "symbol": "326030", "name": "SK Biopharmaceuticals Co., Ltd.", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Price to book forward of SK Biopharmaceuticals Co., Ltd. \u2013 KRX:326030", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQellpSG5EMlpDbEpia2pZTEVSTUc4UzBSOUFEd1Q4NmpPeUFWZ0NKOXh0cEdQU2NOMlJoa1FNZHczTlc5MHRJdWhTVUIyNVU5RHRFZm1YaHdVVFp3eVFNYjA5ZTdIVmdNU05QRXJZYi1rMFlIemZjV0FXYzBra1V0NDlseW9vaVd6WFJ6bWNwUEJfWVBHSHFGT2lSSQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-16T11:07:50+00:00", "published_display": "16 Jul 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Biopharmaceuticals Advances Actinium-Based RPT Cancer Drug Into Clinical Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFB0S3JJTlBNNE93N2lqOTg4ZGJYWktMMjNvbm9HUFMwMlB3RjJvX0FRSnJBa19RU3ZZbmpieVBkS005blpjWGF6UmNVRmZuRXU3QjFDUk1zYnE3Y3hMWjdBN2JkS2tYZw?oc=5", "source_name": "thelec.net", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Biopharmaceuticals Co., Ltd. | 326030.KS Stock Price & Real-time Quotes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9Fb1BSVTBtNzNIT1I4b1NnOHNJMmpZcEJRUnVnZWpmdWlZaThpdEtwYUtNR3B4d0hGb1FBSUluZWtuQy1vRTQxY2xyWTgzRGdCZTdV?oc=5", "source_name": "finance.biggo.com", "published_at": "2026-01-17T23:12:41+00:00", "published_display": "17 Jan 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to book forward of SK Biopharmaceuticals Co., Ltd. \u2013 KRX:326030", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQellpSG5EMlpDbEpia2pZTEVSTUc4UzBSOUFEd1Q4NmpPeUFWZ0NKOXh0cEdQU2NOMlJoa1FNZHczTlc5MHRJdWhTVUIyNVU5RHRFZm1YaHdVVFp3eVFNYjA5ZTdIVmdNU05QRXJZYi1rMFlIemZjV0FXYzBra1V0NDlseW9vaVd6WFJ6bWNwUEJfWVBHSHFGT2lSSQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-16T11:07:50+00:00", "published_display": "16 Jul 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Biopharmaceuticals Advances Actinium-Based RPT Cancer Drug Into Clinical Trials", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFB0S3JJTlBNNE93N2lqOTg4ZGJYWktMMjNvbm9HUFMwMlB3RjJvX0FRSnJBa19RU3ZZbmpieVBkS005blpjWGF6UmNVRmZuRXU3QjFDUk1zYnE3Y3hMWjdBN2JkS2tYZw?oc=5", "source_name": "thelec.net", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Biopharmaceuticals Co., Ltd. | 326030.KS Stock Price & Real-time Quotes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9Fb1BSVTBtNzNIT1I4b1NnOHNJMmpZcEJRUnVnZWpmdWlZaThpdEtwYUtNR3B4d0hGb1FBSUluZWtuQy1vRTQxY2xyWTgzRGdCZTdV?oc=5", "source_name": "finance.biggo.com", "published_at": "2026-01-17T23:12:41+00:00", "published_display": "17 Jan 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 50, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 82400.0, "latest_week": "2026-07-10", "one_week_move": -4.4, "four_week_move": -6.3, "twelve_week_move": -21.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.934814, "market_dynamics_buy_signal": false, "relative_strength": -52.896105, "fair_value_gap": -16.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.1615, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.4% over one week, -6.3% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 1}, {"label": "thelec.net", "count": 1}, {"label": "finance.biggo.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.4% over one week, -6.3% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to book forward of SK Biopharmaceuticals Co., Ltd. \u2013 KRX:326030"}], "updated_at": "2026-07-17T17:02:56.765414+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}